$DHAI
DIH Holding US Inc Stock $dhai

$dhai Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223029608 Filed on August 21, 2023

Income Statement

Concept	2023 Q2	2022 Q2
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue	$7.648M
YoY Change
Gross Profit	$5.397M
YoY Change
Gross Profit Margin
Selling, General & Admin	$5.837M
YoY Change
% of Gross Profit	108.15%
Research & Development	$1.438M
YoY Change
% of Gross Profit	26.64%
Depreciation & Amortization	$79.00K
YoY Change
% of Gross Profit	1.46%
Operating Expenses	$837.6K	-$1.393M
YoY Change	-160.14%
Operating Profit	-$837.6K	-$193.7K
YoY Change	332.46%
Interest Expense	$697.2K	$1.393M
YoY Change	-49.93%
% of Operating Profit
Other Income/Expense, Net	$988.4K	$1.393M
YoY Change	-29.02%
Pretax Income	$150.8K	$1.199M
YoY Change	-87.42%
Income Tax	$226.0K
% Of Pretax Income	149.83%
Net Earnings	$150.8K	$1.199M
YoY Change	-87.42%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.12
Diluted Earnings Per Share	$0.01	$46.92K
COMMON SHARES
Basic Shares Outstanding	25.00M
Diluted Shares Outstanding	25.00M

Balance Sheet

Concept	2023 Q2	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.190K	$391.2K
YoY Change	-98.42%
Cash & Equivalents	$6.193K	$391.2K
Short-Term Investments
Other Short-Term Assets	$84.60K	$503.1K
YoY Change	-83.18%
Inventory
Prepaid Expenses	$84.60K	$503.1K
Receivables
Other Receivables
Total Short-Term Assets	$90.79K	$894.3K
YoY Change	-89.85%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$60.20M	$204.3M
YoY Change	-70.53%
Other Assets		$63.23K
YoY Change
Total Long-Term Assets	$60.20M	$204.3M
YoY Change	-70.54%
TOTAL ASSETS
Total Short-Term Assets	$90.79K	$894.3K
Total Long-Term Assets	$60.20M	$204.3M
Total Assets	$60.29M	$205.2M
YoY Change	-70.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$434.5K	$140.2K
YoY Change	209.91%
Accrued Expenses	$1.782M	$64.51K
YoY Change	2662.34%
Deferred Revenue
YoY Change
Short-Term Debt	$850.0K	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.116M	$204.7K
YoY Change	1422.38%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$7.447M	$8.075M
YoY Change	-7.77%
Total Long-Term Liabilities	$7.447M	$8.075M
YoY Change	-7.77%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.116M	$204.7K
Total Long-Term Liabilities	$7.447M	$8.075M
Total Liabilities	$10.56M	$8.279M
YoY Change	27.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.47M	-$7.322M
YoY Change	43.03%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$10.47M	-$7.322M
YoY Change
Total Liabilities & Shareholders Equity	$60.29M	$205.2M
YoY Change	-70.62%

Cashflow Statement

Concept	2023 Q2	2022 Q2
OPERATING ACTIVITIES
Net Income	$150.8K	$1.199M
YoY Change	-87.42%
Depreciation, Depletion And Amortization	$79.00K
YoY Change
Cash From Operating Activities	-$223.6K	-$163.2K
YoY Change	36.99%
INVESTING ACTIVITIES
Capital Expenditures	$15.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$405.0K	$0.00
YoY Change
Cash From Investing Activities	-$405.0K	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	625.0K	-39.37K
YoY Change	-1687.5%
NET CHANGE
Cash From Operating Activities	-223.6K	-163.2K
Cash From Investing Activities	-405.0K	0.000
Cash From Financing Activities	625.0K	-39.37K
Net Change In Cash	-3.630K	-202.6K
YoY Change	-98.21%
FREE CASH FLOW
Cash From Operating Activities	-$223.6K	-$163.2K
Capital Expenditures	$15.00K
Free Cash Flow	-$238.6K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001883788
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2022Q1	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
	ATAK	Allocation Of Deferred Offering Costs For Warrant Liability AllocationOfDeferredOfferingCostsForWarrantLiability		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments		usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities		usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt		usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
	ATAK	Initial Measurement Of Classa Ordinary Shares Subject To Possible Redemption InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption		usd
	ATAK	Initial Measurement Of Public Warrants And Private Placement Warrants InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants		usd
	ATAK	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable		usd
	ATAK	Forfeiture Of Representative Shares ForfeitureOfRepresentativeShares		usd
	ATAK	Stock Issued During Period Representative Shares Issued Value Class A StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA		usd
	ATAK	Deferred Offering Costs Incurred Included In Accrued Offering Costs DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41250
	dei	Entity Registrant Name EntityRegistrantName	AURORA TECHNOLOGY ACQUISITION CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1624542
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4 Embarcadero Center
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1449
	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94105
	dei	City Area Code CityAreaCode	(650)
	dei	Local Phone Number LocalPhoneNumber	550-0458
	dei	Security12b Title Security12bTitle	Class A Ordinary Share, par value $0.0001 per share
	dei	Trading Symbol TradingSymbol	ATAK
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	us-gaap	Cash Cash	6193	usd
CY2022Q4	us-gaap	Cash Cash	191103	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	84597	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	284597	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	90790	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	475700	usd
CY2023Q2	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	60198874	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	206879903	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	60198874	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	206879903	usd
CY2023Q2	us-gaap	Assets Assets	60289664	usd
CY2022Q4	us-gaap	Assets Assets	207355603	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	434496	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	30132	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1781983	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	357026	usd
CY2023Q2	ATAK	Accrued Offering Costs AccruedOfferingCosts	50000	usd
CY2022Q4	ATAK	Accrued Offering Costs AccruedOfferingCosts	50000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3116479	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	437158	usd
CY2023Q2	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	376820	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	589420	usd
CY2023Q2	ATAK	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	7070000	usd
CY2022Q4	ATAK	Deferred Underwriting Commissions Noncurrent DeferredUnderwritingCommissionsNoncurrent	7070000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7446820	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	7659420	usd
CY2023Q2	us-gaap	Liabilities Liabilities	10563299	usd
CY2022Q4	us-gaap	Liabilities Liabilities	8096578	usd
CY2023Q2	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.62
CY2022Q4	us-gaap	Temporary Equity Redemption Price Per Share TemporaryEquityRedemptionPricePerShare	10.24
CY2023Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	60198874	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	206879903	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10473044	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7621413	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-10472509	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7620878	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	60289664	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	207355603	usd
CY2023Q2	ATAK	Formation And Operating Costs FormationAndOperatingCosts	837555	usd
CY2022Q2	ATAK	Formation And Operating Costs FormationAndOperatingCosts	193673	usd
	ATAK	Formation And Operating Costs FormationAndOperatingCosts	2389231	usd
	ATAK	Formation And Operating Costs FormationAndOperatingCosts	991071	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-837555	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-193673	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2389231	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-991071	usd
CY2023Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-291180	usd
CY2022Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-1139452	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-212600	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4776047	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	258440	usd
CY2023Q2	us-gaap	Investment Income Dividend InvestmentIncomeDividend	697219	usd
CY2022Q2	us-gaap	Investment Income Dividend InvestmentIncomeDividend	253141	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1966104	usd
	us-gaap	Investment Income Dividend InvestmentIncomeDividend	253141	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	988399	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1392593	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2178704	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5287628	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	150844	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1198920	usd
	us-gaap	Net Income Loss NetIncomeLoss	-210527	usd
	us-gaap	Net Income Loss NetIncomeLoss	4296557	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-7620878	usd
CY2023Q1	ATAK	Remeasurement Of Redemption Value RemeasurementOfRedemptionValue	-1538885	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-361371	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-9521134	usd
CY2023Q2	ATAK	Remeasurement Of Redemption Value RemeasurementOfRedemptionValue	-1102219	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	150844	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-10472509	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	15037	usd
CY2022Q1	ATAK	Remeasurement Of Redemption Value RemeasurementOfRedemptionValue	-30006587	usd
CY2022Q1	ATAK	Stock Issued During Period Representative Shares Issued Value StockIssuedDuringPeriodRepresentativeSharesIssuedValue	3030000	usd
CY2022Q1	ATAK	Rights Underlying The Units Value RightsUnderlyingTheUnitsValue	15596420	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	3097637	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-8267493	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-8267493	usd
CY2022Q2	ATAK	Remeasurement Of Redemption Value RemeasurementOfRedemptionValue	-253141	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1198920	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	1198920	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-7321714	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-7321714	usd
	us-gaap	Net Income Loss NetIncomeLoss	-210527	usd
	us-gaap	Net Income Loss NetIncomeLoss	4296557	usd
	ATAK	Investmentincomedividends Investmentincomedividends	1966104	usd
	ATAK	Investmentincomedividends Investmentincomedividends	253141	usd
	ATAK	Allocation Of Deferred Offering Costs For Warrant Liability AllocationOfDeferredOfferingCostsForWarrantLiability	516746	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-212600	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-4776047	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	258440	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-200000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	566336	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1829321	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	130252	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-359910	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-910409	usd
	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	204020000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	675000	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	149322133	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	148647133	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-204020000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	202000000	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6470000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2525000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	850000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	242801	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	446002	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	149322133	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-148472133	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	205256197	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-184910	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	325788	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	191103	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65373	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6193	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	391161	usd
	ATAK	Initial Measurement Of Classa Ordinary Shares Subject To Possible Redemption InitialMeasurementOfClassaOrdinarySharesSubjectToPossibleRedemption	174013413	usd
	ATAK	Initial Measurement Of Public Warrants And Private Placement Warrants InitialMeasurementOfPublicWarrantsAndPrivatePlacementWarrants	5780547	usd
	ATAK	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	7070000	usd
	ATAK	Remeasurement Of Class A Ordinary Shares Subject To Possible Redemption RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption	2641104	usd
	ATAK	Remeasurement Of Class A Ordinary Shares Subject To Possible Redemption RemeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption	30259728	usd
	ATAK	Forfeiture Of Representative Shares ForfeitureOfRepresentativeShares	-70	usd
	ATAK	Stock Issued During Period Representative Shares Issued Value Class A StockIssuedDuringPeriodRepresentativeSharesIssuedValueClassA	30	usd
	ATAK	Deferred Offering Costs Incurred Included In Accrued Offering Costs DeferredOfferingCostsIncurredIncludedInAccruedOfferingCosts	64512	usd
CY2022Q1	ATAK	Overallotment Option Liability OverallotmentOptionLiability	258440	usd
CY2022Q1	ATAK	Stock Issued During Period Representative Shares Issued Value StockIssuedDuringPeriodRepresentativeSharesIssuedValue	3030000	usd
CY2022Q1	ATAK	Rights Underlying The Units Value RightsUnderlyingTheUnitsValue	15596420	usd
CY2022Q1	us-gaap	Cash Cash	1468333	usd
CY2023Q2	us-gaap	Deposits Deposits	675000	usd
CY2023Q2	ATAK	Percentage Of Fair Market Value Of Target Business To Asset Held In Trust Account PercentageOfFairMarketValueOfTargetBusinessToAssetHeldInTrustAccount	0.80	pure
CY2023Q2	us-gaap	Minimum Net Worth Required For Compliance MinimumNetWorthRequiredForCompliance	5000001	usd
	ATAK	Business Combination Extension Of Business Combination Period BusinessCombinationExtensionOfBusinessCombinationPeriod	extends the period of time to consummate the initial Business Combination up to six times, each by an additional one month (for a total of up to 24 months from the date of the Initial Public Offering to complete the Business Combination),
	ATAK	Number Of Days Within Which Public Shares Shall Be Redeemed NumberOfDaysWithinWhichPublicSharesShallBeRedeemed	P10D
CY2023Q2	us-gaap	Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities	50000	usd
CY2023Q2	us-gaap	Cash Cash	6193	usd
CY2022Q4	us-gaap	Cash Cash	191103	usd
CY2023Q2	ATAK	Net Working Capital Surplus Deficit NetWorkingCapitalSurplusDeficit	-3025689	usd
CY2022Q4	ATAK	Net Working Capital Surplus Deficit NetWorkingCapitalSurplusDeficit	38542	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zq9ZrKAgf3ua" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86B_zMEeLlEJonx4">Use of Estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q2	ATAK	Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated	1	pure
CY2022Q1	ATAK	Overallotment Option Liability OverallotmentOptionLiability	258440	usd
CY2022Q1	ATAK	Stock Issued During Period Representative Shares Issued Value StockIssuedDuringPeriodRepresentativeSharesIssuedValue	3030000	usd
CY2022Q1	ATAK	Rights Underlying The Units Value RightsUnderlyingTheUnitsValue	15596420	usd
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Shares StockRedeemedOrCalledDuringPeriodShares	14529877	shares
CY2023Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	149322133	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_z49JUe7gKpV2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zVwzPGBVncb3">Concentration of Credit Risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $<span id="xdx_90B_eus-gaap--CashFDICInsuredAmount_iI_c20230630_zPyGgY4R5izf" title="Federal depository insurance coverage">250,000</span>. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	26670000	shares
	ATAK	Minimum Lock In Period For Transfer Assign Or Sell Warrants After Completion Of Ipo MinimumLockInPeriodForTransferAssignOrSellWarrantsAfterCompletionOfIpo	P30D
CY2023Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	376820	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	589420	usd

Files In Submission

Name	View Source	Status
0001493152-23-029608-index-headers.html	Edgar Link	pending
0001493152-23-029608-index.html	Edgar Link	pending
0001493152-23-029608.txt	Edgar Link	pending
0001493152-23-029608-xbrl.zip	Edgar Link	pending
atak-20230331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
atak-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
atak-20230331_def.xml	Edgar Link	unprocessable
atak-20230331_pre.xml	Edgar Link	unprocessable
atak-20230331_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DHAI
DIH Holding US Inc Stock $dhai

2023 Q2 Form 10-Q Financial Statement

#000149315223029608 Filed on August 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DHAI DIH Holding US Inc Stock $dhai

2023 Q2 Form 10-Q Financial Statement

#000149315223029608 Filed on August 21, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DHAI
DIH Holding US Inc Stock $dhai